Diagnosing Strategic Performance

The dashboard that hid strategic drift

Veridian's board deck showed green ARR growth (+22% YoY) but yellow logo churn (8% annual) and rising discount rate. Anita asked: "Are we growing into weaker positions?" Strategic performance diagnosis connects financial outcomes to positioning and capability hypotheses—not only variance explanations.

Diagnosis precedes prescription. Before Leo recommends healthcare focus or pricing fixes, he assembles evidence on industry structure, relative share, unit economics, and activity-system health.

This lesson introduces a disciplined diagnostic sequence you will reuse through STR 301 and in the Unit 6 board memo.

Veridian Cloud is a B2B workflow automation SaaS platform for mid-market and enterprise operations teams and the anchor company for STR 301. As of the latest reporting period, Veridian reports $95M ARR (annual recurring revenue, subscription revenue normalized to a year), 1.12 net revenue retention (NRR, revenue from existing customers including expansion minus churn), and 2,800 customers with average contract value near $34k. CEO Anita Desai, VP Strategy Leo Hartmann, and CFO Priya Nair lead industry analysis, moat assessment, and corporate scope decisions across Workflow Studio (core orchestration), Integration Hub (1,400+ certified connectors), and AI Assist (document routing and approval prediction).

You will apply Porter's industry frameworks, the resource-based view (RBV), business-level positioning, and corporate strategy tools to Veridian's real strategic tensions—not abstract case studies.

Diagnostic sequence

1. Clarify strategic intent (chosen where/how). 2) Measure outcomes (ARR, NRR, win rate, margin). 3) Decompose industry vs firm effects. 4) Test activity-system links (SLA, certification pipeline). 5) Compare to strategic groups and rivals. 6) Prescribe with trade-offs.

Leading versus lagging indicators

Lagging: ARR, churn, EBIT. Leading: pipeline quality, implementation backlog, connector certification velocity, competitive win themes. Veridian's strategic drift appears in leading indicators—discount requests before renewals—before ARR stalls.

Profit formula linkage

Translate KPIs into a profit formula: Profit ≈ Customers × ARPU × Gross margin − S&M − R&D. Veridian can grow customers while destroying profit if ACV falls faster than volume rises. Diagnosis asks which lever mismatches strategy.

Strategic health versus financial health

Financial health can mask strategic sickness—discounting buys logos. Strategic health asks whether wins strengthen position: target segment mix, module attach, referenceability in regulated industries.

Board-ready diagnostic narrative

Structure: current strategy in one paragraph; performance vs peers; industry vs firm split; activity-system stress points; two strategic options with trade-offs. Leo prepares this quarterly so Unit 6 memo writing feels familiar.

Data: ARR +22%, NRR 1.12→1.09, win rate 34%→29%, discount 11%→15%, healthcare NRR 1.21, services hours +18%.

Part A: Intent vs outcome

Intent: regulated mid-market with fast deployments. Outcome mixed: healthcare strong, general mid-market softening.

Part B: Activity stress

Services hours up suggests scope creep breaking SLA model; discounting compensates for slower value proof.

Part C: Prescription options

Option A: Enforce deal desk + healthcare weighting. Option B: Reset positioning to horizontal scale (rejects trade-offs). Leo recommends A with pricing governance.

Part D: Managerial read

Anita accepts NRR softness as early warning—not waits for ARR cliff.

A fictional martech vendor celebrated logo count while ACV halved. Veridian diagnoses segment mix and margin, not only ARR headlines.

Given: expansion attach 38%→31%, AI Assist NPS high, sales blames procurement delays.

Build a mini diagnostic: intent, outcomes, industry vs firm hypothesis, one leading indicator to investigate, one prescription with trade-off.

Solution

Intent: land-and-expand via modules. Outcome: expansion weakens—firm effect likely (attach drop) with possible industry procurement drag.

Investigate day-60 CS expansion playbook completion rate (leading).

Prescription: Reinforce expansion plays before new logo incentives; trade-off—slow new logo contests short term.

Key takeaways

• Diagnose before prescribing; use a repeatable six-step sequence.
• Leading indicators expose strategic drift before ARR breaks.
• Link KPIs to profit formula and positioning intent.
• Separate healthcare strength from general mid-market weakness.
• Board narratives need options, trade-offs, and peer context.

1. Run the six-step diagnostic on your company using real or plausible data.
2. Identify two leading indicators for strategic health.
3. Begin Unit 2 with Five Forces applied to workflow automation.

Applying Diagnosing Strategic Performance at Veridian Cloud scale

When Veridian Cloud evaluates diagnosing strategic performance, Leo Hartmann's strategy team starts from operating facts: $95M ARR, 1.12 NRR, 2,800 customers, and 8% annual logo churn. CEO Anita Desai, VP Strategy Leo Hartmann, and CFO Priya Nair align strategy foundations and performance diagnosis with quarterly business reviews and board prep. A framework that stays abstract fails Anita Desai's test: can we explain why Veridian wins deals against ServiceNow and Salesforce Flow, and what we will not do?

Consider how a 2-point improvement in win rate affects Veridian. At 34% baseline and roughly 400 qualified enterprise opportunities per year, a move to 36% yields eight additional wins. With $34k ACV and 78% gross margin, eight wins add roughly $0M in gross profit over initial contract terms before expansion. That is why diagnosing strategic performance is not classroom vocabulary for Veridian; it is how the company avoids funding initiatives that sound strategic but do not change competitive outcomes.

The strategy foundations and performance diagnosis workflow at Veridian separates industry attractiveness claims from firm-specific advantage claims. Industry analysis answers whether workflow automation SaaS is structurally attractive. RBV and VRIO answer whether Veridian's connector library and CS playbooks are scarce and hard to imitate. Business-level strategy answers whether Veridian competes on cost, differentiation, or focus—and which trade-offs Anita will enforce. Corporate strategy answers build versus buy, vertical scope, and M&A. Label each slide in Leo's deck with the question it answers before numbers appear.

Extended Veridian scenario: cross-functional read

Imagine Veridian's Q3 strategy review for diagnosing strategic performance. Sales asks whether to match a competitor's 20% list-price cut on Enterprise. Product asks whether AI Assist should ship as platform-wide or healthcare-only. Finance asks whether a tuck-in acquisition accelerates connector coverage faster than internal build. A weak strategy foundations and performance diagnosis answer addresses only one function. A strong answer chains frameworks: five-forces pressure on buyer power informs pricing response; VRIO on integration IP informs build versus buy; corporate scope rules inform M&A screening.

Work the arithmetic on a conservative example. Suppose Veridian's NRR falls from 1.12 to 1.06 because competitive discounting pulls expansion modules forward without adding seats. On a $95M ARR base, that 6-point NRR gap versus plan implies roughly $6M less expansion revenue over the next year if cohort behavior persists. Pair the point estimate with strategic logic: is the NRR miss industry-wide price pressure (industry effect) or a positioning mistake (firm effect)? Diagnosing Strategic Performance gives vocabulary to separate those explanations before Anita approves a hiring plan.

Stakeholder conflict is normal. Sales wants flexibility; product wants focus; finance wants payback discipline. Diagnosing Strategic Performance gives you language to negotiate with explicit trade-offs rather than slogans. If evidence is industry-level only, the decision may be ride the cycle or exit a segment—not copy a competitor's feature list. If evidence is firm-level capability gap, the decision is invest, partner, or acquire with a timeline.

Technical mechanics and checks (strategy patterns)

For diagnosing strategic performance, Veridian analysts show reconciliations the way finance shows bridge charts. A five-forces table lists force, rating (low/medium/high), evidence, and implication for margin or growth. A VRIO row names a resource, scores V-R-I-O, and states competitive implication (parity, temporary advantage, sustained advantage). A strategic group map plots price versus breadth with Veridian, ServiceNow, Zapier, and Monday positioned explicitly. A value curve compares factors (implementation speed, connector depth, compliance, AI, TCO) with relative scores.

Use plain-language hypotheses before matrices. Example: "Buyer power rises if IT procurement mandates three-bid RFPs on renewals above $250k." Test with win-loss data and discount depth by deal size. Example: "Integration Hub is inimitable if certification requires 18-month partner co-development." Test with engineer interviews and competitor connector counts. Strategy frameworks are hypotheses until evidence fills cells.

For spreadsheet replication, write the unit of analysis first. Industry analysis uses market-year panels. Firm analysis uses Veridian fiscal year or customer cohort. Competitor analysis uses named rivals and product modules. Corporate M&A uses target-level revenue and synergy categories. Leo's team rejects slides that mix units without labeling.

Common executive questions (and disciplined answers)

Executives ask short questions that require long disciplined answers. "Are we differentiated?" maps to VRIO and value curves, not adjectives. "Should we buy them?" maps to scope, synergies, integration risk, and alternate build/partner paths. "Is the market attractive?" maps to five forces and life-cycle stage, not TAM headlines. "Why did we lose?" maps to competitor analysis and response anticipation, not anecdote from one rep.

Veridian's credible answer format for diagnosing strategic performance is three bullets: strategic recommendation, framework evidence label (industry vs firm vs corporate), and explicit trade-off rejected. A fourth bullet states what would falsify the recommendation within two quarters. That discipline prevents strategy decks from becoming either vision poetry or spreadsheet dumps.

Practice the loop until it is habit. Diagnose performance → classify industry versus firm effects → analyze structure and rivals → audit resources → choose business-level position → decide corporate scope → plan execution and response. When the loop is complete, Veridian funds what survives skepticism.

Practice extension: self-check without peeking

Before re-reading solutions, open a blank document and complete four rows. Row one: write Veridian's strategic decision that diagnosing strategic performance informs. Row two: name the framework primary cells you must fill (forces, VRIO rows, scope options). Row three: list one industry effect and one firm effect that could explain the same KPI miss. Row four: state the trade-off Anita should enforce if the analysis is correct. Compare your rows to the worked example. Gaps indicate what to re-read.

If you study outside B2B SaaS, substitute your company but keep numeric discipline. A manufacturer might replace NRR with share of wallet; a retailer might replace connectors with store footprint. The structural habits from STR 301 remain: separate industry from firm, name trade-offs, tie recommendations to evidence, and document what you will not do.

Connection to OMBA 102 and FIN 201

OMBA 102 (business foundations) and FIN 201 (corporate finance) unit economics gave you unit economics and capital discipline. STR 301 adds competitive logic: why some industries earn better returns, why some firms beat rivals in the same industry, and how corporate scope changes risk and return. Treat the stack as one narrative: FIN 201 asks whether a project clears hurdle rate; STR 301 asks whether the project strengthens position or merely spends cash; OMBA 102 asks how confident you should be in the forecast behind both.

When you present to Veridian's board, integrate the stack. Example: FIN 201 models a tuck-in acquisition IRR; STR 301 scores target fit on five forces post-merger and VRIO on connector IP; OMBA 102 stress-tests synergy timing. Capstone memos in Unit 6 require that integrated arc.

Deep dive: metrics Veridian reuses every quarter

ARR sums contracted recurring revenue normalized to a year. NRR divides expansion plus retained revenue by prior-year cohort revenue; values above 1.0 mean expansion outweighs churn. GRR (gross revenue retention) measures retained revenue before expansion—Veridian targets 92%. ACV averages first-year contract value per new logo. Win rate counts competitive wins divided by qualified opportunities with documented outcomes. Sales cycle measures days from qualified opportunity to signature. Logo churn counts lost customers divided by starting customers for the year.

These definitions appear boring until someone changes them silently. A definitional shift in NRR can fake a turnaround. Diagnosing Strategic Performance training includes insisting on definition footers in every strategy exhibit. When Veridian compares industry benchmarks to internal dashboards, shared definitions are the chain between Porter and proof.

For strategy foundations and performance diagnosis, document evidence sources and refresh cadence. CRM win-loss updates weekly; product usage for expansion scoring updates nightly; competitor intelligence from field teams batches monthly; board strategy metrics freeze quarterly. A framework exhibit without data timestamp and owner is opinion.

Walk through a reconciliation each quarter. Starting ARR plus new ARR minus churned ARR should approximate ending ARR within known timing differences. Win-rate denominators should match CRM stage definitions. Five-forces ratings should cite dated evidence, not last year's board deck recycled.

Managerial judgment prompts for Diagnosing Strategic Performance

1. If evidence supports industry headwinds only, what scope or positioning change should Veridian consider?
2. If sales requests a price match and product requests roadmap acceleration, what trade-off does diagnosing strategic performance force?
3. Which stakeholder loses most if Veridian pursues a false differentiation story?
4. What would a smart skeptic ask about survivorship bias in competitor benchmarks?
5. What single metric movement would convince you the current strategy is wrong?

Write ninety-word answers as a memo appendix. Use Veridian numbers wherever possible. This exercise converts lesson prose into decision reflexes under time pressure.

Additional study path: compare this lesson's worked example to the practice problem. Identify one assumption that changed and explain how that change alters Anita's decision. Then preview Unit 6's board memo structure: decision ask, framework evidence, trade-offs, execution risks, and falsification triggers. Courses compound when you reuse the same company, rivals, and metrics across units.

For strategy foundations and performance diagnosis, also stress-test recommendations with explicit counterfactuals. If Veridian had matched ServiceNow discounting last year, modeled NRR might sit near 1.04 with services margin compressed 3 points—Leo uses such counterfactuals to show why diagnosing strategic performance analysis is not academic. Counterfactuals must use Veridian definitions for ARR, NRR, and discount depth; otherwise debate becomes rhetorical.

Board members will ask "what breaks first?" under stress. Diagnosing Strategic Performance answers should name the first failing link in the activity system—often certification backlog before sales pipeline, or expansion attach before new-logo CAC. Naming the weak link focuses capital on the true bottleneck rather than the loudest department in the room.

When teaching diagnosing strategic performance to cross-functional teams, assign each function one framework column to own in perpetuity: Sales owns win-loss and response anticipation; Product owns value curve and business model experiments; Finance owns profit formula and M&A guardrails; CS owns expansion attach and SLA metrics; Strategy owns five-forces refresh and VRIO audits. Shared ownership without column owners produces slides everyone applauds and nobody maintains.

Finally, compare diagnosing strategic performance conclusions to Veridian's written trade-offs in Lesson 1. If this lesson's recommendation requires violating a named not-doing item, escalate to Anita before execution. Strategy coherence is the difference between a portfolio of smart projects and a company that wins its chosen game.